Medical Condition News

RSS

New method for counting molecules

Researchers at the Swedish medical university Karolinska Institutet have developed a new method for counting molecules.

21 Nov 2011

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.

21 Nov 2011

Yeast protein in vaccines for more efficient immune response

To enhance the efficiency of vaccines, researchers at the division of chemical technology, Luleå University of Technolgy (LTU) have in co-operation with Karolinska Institute and Recopharma AB developed a strategy with the aim of directing vaccine components to critical parts of the immune system so that a more efficient immune response can be generated. The researchers have used a special type of protein produced in yeast.

21 Nov 2011

Retina Implant scientific advisory board approves multi-center phase of second human clinical trial

Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company's second human clinical trial. The trial, which began in Tuebingen, Germany in 2010, will be expanded across Europe in five new sites, including two additional locations in Germany, Oxford, London and Budapest.

21 Nov 2011

American high school students earn top honors for liver disease and brain injury research

The shortlist of contenders for the highest science honor awarded to American high school students narrowed tonight as the winners of the Siemens Competition in Math, Science & Technology Region 3 Finals were announced.

21 Nov 2011

New material emits long-lasting, near-infrared glow after sunlight exposure

Materials that emit visible light after being exposed to sunlight are commonplace and can be found in everything from emergency signage to glow-in-the-dark stickers. But until now, scientists have had little success creating materials that emit light in the near-infrared range, a portion of the spectrum that only can be seen with the aid of night vision devices.

21 Nov 2011

Scientists unravel how brain combines different sensory cues to make sense of our world

The human brain is bombarded with a cacophony of information from the eyes, ears, nose, mouth and skin. Now a team of scientists at the University of Rochester, Washington University in St. Louis, and Baylor College of Medicine has unraveled how the brain manages to process those complex, rapidly changing, and often conflicting sensory signals to make sense of our world.

21 Nov 2011

Promising results from dexpramipexole phase 2 trial on ALS

Treatment with dexpramipexole - a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy - appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Promising results of a phase 2 trial of dexpramipexole are receiving advance online publication in Nature Medicine.

20 Nov 2011

Scientists show that the sense of smell can be improved

In a new study scientists at NYU Langone Medical Center have shown that the sense of smell can be improved. The new findings, published online November 20, 2011, in Nature Neuroscience, suggest possible ways to reverse the loss of smell due to aging or disease.

20 Nov 2011

Two genetic rearrangements may trigger 5 to 7% of breast cancers

Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.

20 Nov 2011

Switching or adding antidepressants does not exacerbate side effects

Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be any more likely to be harmful than the other.

19 Nov 2011

Study: Metabolic syndrome biomarkers predict decline in lung function after WTC dust exposure

Metabolic syndrome biomarkers predict subsequent decline in lung function after particulate exposure, according to new research involving rescue personnel exposed to World Trade Center (WTC) dust.

19 Nov 2011

Experts to discuss new research at IOF Regionals - 1st Latin America Osteoporosis Meeting

Physicians across a broad range of medical fields, clinical researchers and bone experts from throughout Latin America will meet in S-o Paulo, Brazil from May 24-27, 2012 for the region's leading bone event - the IOF Regionals - 1st Latin America Osteoporosis Meeting.

19 Nov 2011

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Heart rate recovery at one minute after a six-minute walking distance (6MWD) test is highly predictive of clinical worsening and time to clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a new study.

19 Nov 2011

Scientists solve mystery behind why people with defective hemoglobin do not contract malaria

Why do people with a hereditary mutation of the red blood pigment hemoglobin not contract severe malaria? Scientists in the group headed by Prof. Michael Lanzer of the Department of Infectious Diseases at Heidelberg University Hospital have now solved this mystery.

19 Nov 2011

Lancet examines WHO Euro Health 2020 initiative

The Lancet examines Health 2020, "a 'process of consultation' between WHO Euro and its 53 diverse member states" that "will build partnerships to tackle the complex determinants and drivers of health and health equity."

19 Nov 2011

Outreach program director at CINJ to take part in unique cancer control program

Kiameesha Evans, MPH, MCHES, program director of the Office of Community Outreach at The Cancer Institute of New Jersey (CINJ), has been selected to take part in a unique pilot program for cancer control practitioners through the National Cancer Institute.

19 Nov 2011

Panel discussion on ethics behind sports concussion treatment

Experts from NYU Langone Medical Center and NYU School of Continuing and Professional Studies' Preston Robert Tisch Center for Hospitality, Tourism and Sports Management held a panel discussion Tuesday night on the ethics of who is responsible for ensuring appropriate medical treatment of an athlete that is injured - particularly if they may have a concussion.

19 Nov 2011

Model NYC program aims to address growing disparities in colon cancer mortality rates

Since the 1970s, U.S. mortality rates due to colorectal cancer have declined overall, yet among blacks and Hispanics, the death rates rose. Evidence suggests that underuse of colonoscopy screening among these groups is one reason for the large disparities. In 2003, New York City launched a multifaceted campaign to improve colonoscopy rates among racial and ethnic minorities and women.

19 Nov 2011

Shire, Shionogi enter agreement to co-develop and co-commercialize ADHD medicines in Japan

Shire plc, the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi & Co. Ltd. of Japan to co-develop and co-commercialize certain of Shire's Attention Deficit Hyperactivity Disorder (ADHD) medicines in Japan.

19 Nov 2011

Medical Condition News

New method for counting molecules

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

Yeast protein in vaccines for more efficient immune response

Retina Implant scientific advisory board approves multi-center phase of second human clinical trial

American high school students earn top honors for liver disease and brain injury research

New material emits long-lasting, near-infrared glow after sunlight exposure

Scientists unravel how brain combines different sensory cues to make sense of our world

Promising results from dexpramipexole phase 2 trial on ALS

Scientists show that the sense of smell can be improved

Two genetic rearrangements may trigger 5 to 7% of breast cancers

Switching or adding antidepressants does not exacerbate side effects

Study: Metabolic syndrome biomarkers predict decline in lung function after WTC dust exposure

Experts to discuss new research at IOF Regionals - 1st Latin America Osteoporosis Meeting

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Scientists solve mystery behind why people with defective hemoglobin do not contract malaria

Lancet examines WHO Euro Health 2020 initiative

Outreach program director at CINJ to take part in unique cancer control program

Panel discussion on ethics behind sports concussion treatment

Model NYC program aims to address growing disparities in colon cancer mortality rates

Shire, Shionogi enter agreement to co-develop and co-commercialize ADHD medicines in Japan

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News